Latest News
Rambus Stock Declines Despite AI-Driven Revenue Growth in Q1
Rambus shares dropped 10.8% after Q1 earnings, despite product revenue climbing 15% on AI demand. The company's cautious Q2 outlook tied to customer deals tempered investor enthusiasm.
Edesa Biotech Surges 54% on Renewed ARDS Drug Optimism
Edesa Biotech (EDSA) shares surged 54% on Monday, driven by renewed interest in February data showing paridiprubart reduced 28-day ARDS mortality to 24% from 33%.
Celestica Shares Dip Despite Strong Earnings and Raised AI-Driven Guidance
Celestica reported Q1 revenue of $4.05B, up 53% YoY, and raised its 2026 outlook to $19B, but shares slipped as the market had already priced in strong AI demand.
XRP Dips 2.7% to $1.39 Despite Ripple-K Bank Pilot, Stablecoin Focus Caps Rally
XRP slipped 2.7% to $1.39 on Monday as Ripple's new pilot with K Bank uses stablecoins, not XRP. The broader crypto market also declined, with bitcoin near $76,960.
AMD Shares Slide on Downgrade Amid AI Rally Skepticism
AMD shares dropped 3.8% after a Northland Capital downgrade questioned the AI rally's sustainability, while Nvidia and Intel gained.
Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial
Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.
Spotty Earnings Ahead: Spotify Launches Peloton Fitness Content
Spotify launches a fitness category with Peloton classes for Premium users, expanding beyond audio. SPOT stock falls ahead of Q1 earnings, while PTON rises.
McDonald's Shares Slide on Downgrade Amid Value War and Netflix Promotion
McDonald's shares dropped nearly 3% after Erste Group downgraded the stock to Hold, citing slower profit growth. The company's upcoming Netflix Happy Meal promotion faces a challenging fast-food environment.
Critical Metals Surges on $835M Deal for Full Greenland Rare Earth Control
Critical Metals Corp. shares jumped after the company agreed to buy European Lithium Ltd. for $835 million, taking full control of Greenland's Tanbreez rare earth project.
Thacker Pass Takes Center Stage as Lithium Americas Stock Surges
Lithium Americas shares rose 13% as focus returns to its Thacker Pass lithium project in Nevada, with the company targeting late 2027 for mechanical completion.
Intellia's CRISPR Therapy for HAE Nears FDA Filing After Late-Stage Success
Intellia Therapeutics (NTLA) announced its CRISPR therapy lonvo-z cut HAE attacks by 87% vs placebo in a Phase 3 trial, with 62% of patients attack-free. A rolling FDA submission has begun.
US Energy Corp Soars 21% on $285/Mcf Helium Deal for Montana Project
U.S. Energy Corp shares jumped 20.8% after signing a five-year helium sales deal at a fixed price of $285 per thousand cubic feet for its Big Sky Carbon Hub.